Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyung-Sang Yu

Showing results (91-100 of 349) with videos related to

Pageof 35
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 15, 2019
A physiologically-based pharmacokinetic model adequately predicted the human pharmacokinetic profiles of YH4808, a novel K<sup>+</sup>-competitive acid blockerHyun A Lee, Kyeong-Ryoon Lee, Seong Bok Jang, et al.
Drug Design, Development and Therapy|April 26, 2016
Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjectsSu-Jin Rhee, SeungHwan Lee, Seo Hyun Yoon, et al.
Translational and Clinical Pharmacology|April 13, 2026
Exploratory comparative pharmacokinetic study of a fixed-dose combination of telmisartan/amlodipine/chlorthalidone: half-dose (20/2.5/6.25 mg) versus conventional dose (40/5/12.5 mg)Kyungrin Chang, Heejae Won, Taewon Lee, et al.
Clinical and Translational Science|December 14, 2022
Pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizersWoo Kyung Chung, Inyoung Hwang, Byungwook Kim, et al.
Frontiers in Pharmacology|May 28, 2021
Current Bioequivalence Study Designs in South Korea: A Comprehensive Analysis of Bioequivalence Study Reports Between 2013 and 2019Ki Young Huh, Eunwoo Kim, Soyoung Lee, et al.
British Journal of Clinical Pharmacology|April 8, 2022
Dose-dependent glucosuria of DWP16001, a novel selective sodium-glucose cotransporter-2 inhibitor, in healthy subjectsJun Gi Hwang, SeungHwan Lee, Wan Huh, et al.
British Journal of Clinical Pharmacology|October 14, 2025
Pharmacokinetics, pharmacodynamics and safety of vutiglabridin after multiple oral administrations in healthy female and obese subjectsSooyoun Lee, Hyun Chul Kim, Young Ran Yoon, et al.
NPJ Vaccines|August 7, 2024
A randomized study to evaluate the safety and immunogenicity of a pentavalent meningococcal vaccineYoonjin Kim, Sungyeun Bae, Kyung-Sang Yu, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 5, 2025
Pharmacokinetic comparison of a fixed-dose combination of telmisartan/rosuvastatin/ezetimibe/amlodipine 80/20/10/5 mg and a loose-dose combination of ezetimibe/rosuvastatin 10/20 mg and telmisartan/amlodipine 80/5 mg in healthy male subjectsSooyoun Lee, Hyun Chul Kim, Kyung Tae Kim, et al.
Translational and Clinical Pharmacology|October 8, 2021
Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platformByungwook Kim, Deok Yong Yoon, SeungHwan Lee, et al.
Pageof 35

Showing results (91-100 of 349) with videos related to

Sort By:
Pageof 35
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 15, 2019
A physiologically-based pharmacokinetic model adequately predicted the human pharmacokinetic profiles of YH4808, a novel K<sup>+</sup>-competitive acid blockerHyun A Lee, Kyeong-Ryoon Lee, Seong Bok Jang, et al.
Drug Design, Development and Therapy|April 26, 2016
Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjectsSu-Jin Rhee, SeungHwan Lee, Seo Hyun Yoon, et al.
Translational and Clinical Pharmacology|April 13, 2026
Exploratory comparative pharmacokinetic study of a fixed-dose combination of telmisartan/amlodipine/chlorthalidone: half-dose (20/2.5/6.25 mg) versus conventional dose (40/5/12.5 mg)Kyungrin Chang, Heejae Won, Taewon Lee, et al.
Clinical and Translational Science|December 14, 2022
Pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizersWoo Kyung Chung, Inyoung Hwang, Byungwook Kim, et al.
Frontiers in Pharmacology|May 28, 2021
Current Bioequivalence Study Designs in South Korea: A Comprehensive Analysis of Bioequivalence Study Reports Between 2013 and 2019Ki Young Huh, Eunwoo Kim, Soyoung Lee, et al.
British Journal of Clinical Pharmacology|April 8, 2022
Dose-dependent glucosuria of DWP16001, a novel selective sodium-glucose cotransporter-2 inhibitor, in healthy subjectsJun Gi Hwang, SeungHwan Lee, Wan Huh, et al.
British Journal of Clinical Pharmacology|October 14, 2025
Pharmacokinetics, pharmacodynamics and safety of vutiglabridin after multiple oral administrations in healthy female and obese subjectsSooyoun Lee, Hyun Chul Kim, Young Ran Yoon, et al.
NPJ Vaccines|August 7, 2024
A randomized study to evaluate the safety and immunogenicity of a pentavalent meningococcal vaccineYoonjin Kim, Sungyeun Bae, Kyung-Sang Yu, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 5, 2025
Pharmacokinetic comparison of a fixed-dose combination of telmisartan/rosuvastatin/ezetimibe/amlodipine 80/20/10/5 mg and a loose-dose combination of ezetimibe/rosuvastatin 10/20 mg and telmisartan/amlodipine 80/5 mg in healthy male subjectsSooyoun Lee, Hyun Chul Kim, Kyung Tae Kim, et al.
Translational and Clinical Pharmacology|October 8, 2021
Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platformByungwook Kim, Deok Yong Yoon, SeungHwan Lee, et al.
Pageof 35